Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
about
Ultrastructure and biochemical composition of paired helical filaments in corticobasal degenerationFamilial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filamentsTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesClinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasComparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's diseaseThe fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brainsNeuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.REVIEW: tau protein pathology in Alzheimer's disease and related disorders.Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy.Selective tau tyrosine nitration in non-AD tauopathies.Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.Brain homogenates from human tauopathies induce tau inclusions in mouse brainIdentifying the genetic components underlying the pathophysiology of movement disorders.Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells."Prion-like" templated misfolding in tauopathies.Progressive supranuclear palsy: clinical and pathological diagnosis.Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.Invited review: Prion-like transmission and spreading of tau pathology.Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.Prion-like propagation as a pathogenic principle in frontotemporal dementia.Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.The Prion-Like Behavior of Assembled Tau in Transgenic Mice.Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation.Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.The tauopathies: toward an experimental animal model.Conformation determines the seeding potencies of native and recombinant Tau aggregates.Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation.Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease.Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.Progressive supranuclear palsy: neuronal and glial cytoskeletal pathology in the higher order processing autonomic nuclei of the lower brainstem.Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases.Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.Tau Pathology in Parkinson's DiseaseEpitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau
P2860
Q24676458-1C303C26-91B8-4A30-BD3D-FF98B3D5C160Q24684804-D2D8E6ED-AFE0-490F-AF8A-3EE5896C7C3FQ26769957-644D61CC-D2E2-4532-806D-85FB6355405DQ27003078-03698F2C-796F-49EE-9516-030AC005DFC9Q28145739-E9676CCC-BE59-4192-997C-9408C366E89DQ28350692-B9828E68-D077-41DD-9C92-C6BDB82A03AEQ30989766-CD933633-53CB-4184-8334-A9EAD782EB98Q33183604-E6748394-4907-4F9A-B700-E8C210C687F4Q33694030-E992E1DD-20BB-4EBC-9B70-EDA8ED99906EQ34722021-5A051DAE-44BE-4963-A9C7-67AC18228D17Q35782573-60C2CE48-2554-43D6-ABFA-764CEEE790D1Q35857967-B173E3F8-D4FC-4FB2-8859-DF0905B6D596Q36507684-46889C48-94A0-4F15-838B-1832D55B0ADEQ36915421-955B2596-A769-41D1-86B6-541B58422E36Q36925207-5F447768-4F40-4992-8A6D-3B85B01170D3Q37515094-3075D922-41A8-47AE-9997-57060623B001Q38099071-0D317FDA-84D5-44F5-A0EC-B7462BB07E7AQ38166808-8EE4E074-DD25-470B-B0C7-F8B3A60C7F84Q38248883-24170F0B-0A86-43C4-BB6F-F4369C75E85AQ38268519-B8C15479-9913-445D-A1C4-7C2C67B5FB18Q38296901-0F000437-0DBF-462C-AC30-77595446DE82Q38922025-2A8C68EB-B6EC-4A5D-AF9D-E41D1519B406Q39021126-840D08A7-7BBE-4AA0-BB40-98CB033B828EQ39035488-9F547F11-A148-4B75-A320-9B34EF062877Q40937237-4AB38932-3E09-4506-B9DF-A35139B966A2Q42049177-02BBC887-FBBE-4A80-8DCC-E46C839B7424Q42850116-5EFF05C1-7EF8-4F2A-A4F4-7383FA7EC93DQ43106197-32CE1DDB-6807-4763-8890-94FF7EEDAAF1Q43767016-E632A243-9920-4748-8474-B494480F89F7Q45780486-720F0332-6E7D-4B2D-97D3-889A91915FA6Q48115922-59674109-0F6F-4BBD-B437-36E80A28FEC2Q48202918-80F7BBF4-E72A-4C77-BCED-45AE5BAB41B4Q48619159-4AC4082D-A98B-45A9-ABD7-F17F5C08CE60Q48686262-8DCFD0C3-009C-4F80-A1E8-D41AD707846AQ53218972-F4755FC2-79B0-42EC-9791-98D589033CBFQ53494884-0B586BB8-533C-4C79-B1D9-2770A842649BQ58586744-C5AC166D-4E41-4A34-B3AD-331702C47BF5Q58708935-6D621D0D-A4A3-4486-ADBF-80415121460B
P2860
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@en
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@nl
type
label
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@en
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@nl
prefLabel
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@en
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@nl
P2093
P2860
P356
P1476
Abnormal Tau proteins in progr ...... eration of the Alzheimer type.
@en
P2093
A Delacourte
F Javoy-Agid
P2860
P2888
P304
P356
10.1007/BF00296367
P50
P577
1991-01-01T00:00:00Z